-
Chinese mainland reports 25 new local COVID-19 cases
NMPA
January 28, 2022
The Chinese mainland on Jan 26 recorded 25 locally transmitted COVID-19 cases, the National Health Commission said on Jan 27.
-
New Covid-19 treatment drug available for use in Ireland
FirstWordPharma
January 28, 2022
Ireland has agreed a supply deal for GlaxoSmithKline's COVID-19 antibody treatment Xevudy (sotrovimab), reported The Irish Times.
-
DCGI approves “Conditional Market Authorisation” of Covaxin and Covishield
ExpressPharma
January 28, 2022
The approval pathways through this route are fast-tracked with certain conditions to enhance the access to certain pharmaceuticals for meeting the emerging needs of drugs or vaccines
-
Delta variant, waning immunity reduced Pfizer vaccine's effectiveness against household transmission
WorldPharmaNews
January 28, 2022
A new study by Yale School of Public Health (YSPH) researchers suggests that the Pfizer-BioNTech vaccine was more than 91% effective at reducing transmission of coronavirus in Israeli households before the emergence of the delta variant.
-
Ocugen to buy Liminal’s vaccine manufacturing facility in Canada
pharmaceutical-business-review
January 28, 2022
US-based Ocugen has signed a letter of intent (LOI) to acquire Liminal Biosciences’ manufacturing site located in Belleville...
-
Months After Moderna Booster, Antibodies Decline Faster With Omicron
drugs.com
January 27, 2022
An initial surge in antibody levels against the Omicron variant after a booster dose of the Moderna COVID vaccine wanes within six months..
-
Third mRNA Vaccine Dose Ups Effectiveness Against Hospitalization
drugs.com
January 27, 2022
Receipt of a third COVID-19 mRNA vaccine dose is associated with increased vaccine effectiveness against COVID-19 hospitalization...
-
Hospital Defends Decision to Deny Heart Transplant to Unvaccinated Man
drugs.com
January 27, 2022
In response to claims that a man was denied a heart transplant because he refused to get vaccinated...
-
Scientists Watch, Worry About New 'Stealth' Version of Omicron Variant
drugs.com
January 27, 2022
A "stealthier" version of the omicron variant that has been spotted in the United States and dozens of other countries...
-
Fast paced trial chasing down COVID-19 symtoms
pharmatimes
January 27, 2022
Ground-breaking trial run by Oxford University has recruited 5000 people and will focus on severe COVID-19 symptoms.